Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:percentage of study population developing cerebrovascular lesions during a period of time
go back to main search page
Accession:CMO:0000932 term browser browse the term
Definition:The number of individuals in a study population which develop new instances of non-tumorous cerebrovascular lesions during a certain period compared to the total number of individuals in the study population, expressed as a percentage. A non-tumorous cerebrovascular lesion is a non-neoplastic, localized, pathological change in the structure of the brain which involves or is caused by a component of the vascular system and/or blood supply of the brain, due to injury or disease; especially one that is circumscribed and well defined.
Synonyms:related_synonym: cerebrovascular lesions incidence;   stroke incidence



show annotations for term's descendants           Sort by:

Term paths to the root